| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.591 | 0.012 | 0.591 | Immunomodulator | 0.265 0.104 CID_66283 | ||
| 0.477 | 0.033 | 0.477 | GABA C receptor rho-3 antagonist | 0.334 0.095 CID_66283 | ||
| 0.454 | 0.059 | 0.454 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.352 0.148 CID_66283 | ||
| 0.394 | 0.006 | 0.394 | Butyrylcholinesterase inhibitor | 0.125 0.044 CID_66283 | ||
| 0.365 | 0.011 | 0.365 | Alpha-N-acetylglucosaminidase inhibitor | 0.228 0.027 CID_66283 | ||
| 0.334 | 0.026 | 0.334 | RNA-directed DNA polymerase inhibitor | 0.301 0.031 CID_66283 | ||
| 0.298 | 0.013 | 0.298 | Acetylcholinesterase inhibitor | 0.267 0.018 CID_66283 | ||
| 0.329 | 0.062 | 0.329 | 5 Hydroxytryptamine release stimulant | 0.167 0.157 CID_66283 | ||
| 0.269 | 0.012 | 0.269 | GABA C receptor agonist | 0.168 0.028 CID_66283 | ||
| 0.312 | 0.063 | 0.312 | Aldehyde oxidase inhibitor | |||
| 0.295 | 0.047 | 0.295 | 5 Hydroxytryptamine uptake stimulant | 0.212 0.131 CID_66283 | ||
| 0.281 | 0.044 | 0.281 | Tyrosine 3 hydroxylase inhibitor | 0.216 0.109 CID_66283 | ||
| 0.239 | 0.015 | 0.239 | Ferrochelatase inhibitor | 0.13 0.048 CID_66283 | ||
| 0.275 | 0.053 | 0.275 | DNA synthesis inhibitor | 0.262 0.059 CID_66283 | ||
| 0.242 | 0.02 | 0.242 | 5 Hydroxytryptamine 3E antagonist | 0.199 0.064 CID_66283 | ||
| 0.292 | 0.1 | 0.292 | Calcium channel activator | |||
| 0.204 | 0.012 | 0.204 | GABA C receptor antagonist | 0.133 0.041 CID_66283 | ||
| 0.194 | 0.016 | 0.194 | Adenylate kinase inhibitor | 0.128 0.038 CID_66283 | ||
| 0.197 | 0.019 | 0.197 | UDP-glucose 4-epimerase inhibitor | 0.118 0.044 CID_66283 | ||
| 0.335 | 0.158 | 0.335 | Caspase 9 stimulant | 0.315 0.177 CID_66283 | ||
| 0.317 | 0.146 | 0.317 | 5 Hydroxytryptamine release inhibitor | |||
| 0.181 | 0.011 | 0.181 | GABA C receptor rho-1 antagonist | 0.12 0.04 CID_66283 | ||
| 0.197 | 0.03 | 0.197 | GABA C receptor rho-2 antagonist | 0.14 0.089 CID_66283 | ||
| 0.208 | 0.043 | 0.208 | Succinate dehydrogenase inhibitor | 0.155 0.103 CID_66283 | ||
| 0.176 | 0.014 | 0.176 | Triose-phosphate isomerase inhibitor | 0.107 0.041 CID_66283 | ||
| 0.21 | 0.057 | 0.21 | Peroxidase inhibitor | |||
| 0.193 | 0.04 | 0.193 | Arachidonic acid antagonist | 0.141 0.099 CID_66283 | ||
| 0.158 | 0.008 | 0.158 | Acyl-CoA dehydrogenase inhibitor | 0.089 0.019 CID_66283 | ||
| 0.165 | 0.017 | 0.165 | Ca2+-transporting ATPase inhibitor | 0.144 0.058 CID_66283 | ||
| 0.162 | 0.015 | 0.162 | NADH dehydrogenase inhibitor | 0.11 0.035 CID_66283 | ||
| 0.194 | 0.049 | 0.194 | Cholinergic | 0.152 0.075 CID_66283 | ||
| 0.212 | 0.07 | 0.212 | Nitric-oxide synthase stimulant | |||
| 0.158 | 0.017 | 0.158 | Phosphofructokinase-1 inhibitor | 0.093 0.035 CID_66283 | ||
| 0.189 | 0.052 | 0.189 | Phospholipase C inhibitor | 0.138 0.134 CID_66283 | ||
| 0.162 | 0.026 | 0.162 | Mucolytic | 0.103 0.074 CID_66283 | ||
| 0.155 | 0.025 | 0.155 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.086 0.071 CID_66283 | ||
| 0.152 | 0.023 | 0.152 | Creatine kinase inhibitor | 0.117 0.043 CID_66283 | ||
| 0.148 | 0.021 | 0.148 | Porphobilinogen synthase inhibitor | 0.066 0.06 CID_66283 | ||
| 0.138 | 0.013 | 0.138 | Carbamoyl phosphate synthetase inhibitor | 0.091 0.024 CID_66283 | ||
| 0.166 | 0.04 | 0.166 | Adenylate cyclase stimulant | 0.129 0.105 CID_66283 | ||
| 0.163 | 0.04 | 0.163 | Alkylator | 0.157 0.043 CID_66283 | ||
| 0.221 | 0.099 | 0.221 | DNA damaging | 0.189 0.125 CID_66283 | ||
| 0.139 | 0.018 | 0.139 | Glutamate dehydrogenase inhibitor | 0.088 0.038 CID_66283 | ||
| 0.167 | 0.047 | 0.167 | Bone formation stimulant | |||
| 0.194 | 0.077 | 0.194 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | |||
| 0.25 | 0.135 | 0.25 | Vasodilator, coronary | |||
| 0.165 | 0.053 | 0.165 | Mannose-6-phosphate isomerase inhibitor | 0.114 0.112 CID_66283 | ||
| 0.119 | 0.014 | 0.119 | Biliverdin reductase inhibitor | 0.065 0.035 CID_66283 | ||
| 0.238 | 0.134 | 0.238 | Cholesterol antagonist | |||
| 0.186 | 0.083 | 0.186 | Anesthetic general | |||
| 0.212 | 0.113 | 0.212 | Immunostimulant | 0.185 0.13 CID_66283 | ||
| 0.138 | 0.041 | 0.138 | Expectorant | |||
| 0.248 | 0.156 | 0.248 | Histamine release inhibitor | |||
| 0.126 | 0.039 | 0.126 | DOPA decarboxylase inhibitor | |||
| 0.132 | 0.046 | 0.132 | Aminopeptidase B inhibitor | |||
| 0.099 | 0.014 | 0.099 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.062 0.032 CID_66283 | ||
| 0.115 | 0.031 | 0.115 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.097 0.039 CID_66283 | ||
| 0.107 | 0.026 | 0.107 | Glutamate decarboxylase inhibitor | 0.069 0.056 CID_66283 | ||
| 0.123 | 0.042 | 0.123 | Urease inhibitor | 0.121 0.044 CID_66283 | ||
| 0.12 | 0.04 | 0.12 | Anabolic | |||
| 0.086 | 0.007 | 0.086 | Glucose-6-phosphate isomerase inhibitor | 0.061 0.018 CID_66283 | ||
| 0.178 | 0.101 | 0.178 | Neurotrophic factor enhancer | |||
| 0.235 | 0.161 | 0.235 | Immunosuppressant | |||
| 0.097 | 0.028 | 0.097 | Estrogen-related receptor beta agonist | |||
| 0.09 | 0.021 | 0.09 | Alcohol oxidase inhibitor | |||
| 0.091 | 0.022 | 0.091 | Argininosuccinate synthase inhibitor | 0.051 0.046 CID_66283 | ||
| 0.098 | 0.029 | 0.098 | Aminopeptidase I inhibitor | 0.098 0.029 CID_66283 | ||
| 0.112 | 0.044 | 0.112 | Prolactin inhibitor | |||
| 0.12 | 0.058 | 0.12 | Cystathionine beta-synthase inhibitor | |||
| 0.084 | 0.023 | 0.084 | Glutamate (mGluR7) antagonist | |||
| 0.082 | 0.022 | 0.082 | Glutamate (mGluR6) antagonist | 0.064 0.055 CID_66283 | ||
| 0.139 | 0.08 | 0.139 | Heat shock protein 70 antagonist | |||
| 0.086 | 0.027 | 0.086 | S-adenosyl-L-methionine decarboxylase inhibitor | |||
| 0.109 | 0.05 | 0.109 | Sphingomyelinase inhibitor | 0.103 0.057 CID_66283 | ||
| 0.073 | 0.017 | 0.073 | Aconitate hydratase inhibitor | |||
| 0.099 | 0.044 | 0.099 | Glutamate release inhibitor | |||
| 0.104 | 0.052 | 0.104 | Glutamate (mGluR7) agonist | |||
| 0.092 | 0.041 | 0.092 | D-Ala-D-Ala ligase inhibitor | |||
| 0.077 | 0.027 | 0.077 | Purinergic P2X1 antagonist | |||
| 0.073 | 0.023 | 0.073 | Potassium channel intermediate-conductance Ca-activated blocker | 0.07 0.026 CID_66283 | ||
| 0.091 | 0.042 | 0.091 | Glycine receptor antagonist | |||
| 0.083 | 0.035 | 0.083 | Vanilloid 4 agonist | |||
| 0.067 | 0.019 | 0.067 | H+/K+-transporting ATPase inhibitor | |||
| 0.184 | 0.137 | 0.184 | Superoxide dismutase inhibitor | |||
| 0.066 | 0.02 | 0.066 | Alpha-mannosidase inhibitor | |||
| 0.127 | 0.086 | 0.127 | Protein kinase stimulant | |||
| 0.091 | 0.05 | 0.091 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.086 | 0.045 | 0.086 | Na+ K+ transporting ATPase inhibitor | |||
| 0.18 | 0.139 | 0.18 | Interleukin agonist | |||
| 0.067 | 0.027 | 0.067 | Ornithine carbamoyltransferase inhibitor | |||
| 0.099 | 0.059 | 0.099 | Electrolyte absorption antagonist | |||
| 0.08 | 0.041 | 0.08 | GABA B receptor agonist | |||
| 0.068 | 0.029 | 0.068 | Carbonic anhydrase VB inhibitor | 0.065 0.031 CID_66283 | ||
| 0.198 | 0.16 | 0.198 | Insulysin inhibitor | |||
| 0.051 | 0.013 | 0.051 | Fumarate hydratase inhibitor | |||
| 0.091 | 0.054 | 0.091 | Histamine N-methyltransferase inhibitor | |||
| 0.049 | 0.012 | 0.049 | Glutamate (mGluR8) agonist | 0.036 0.03 CID_66283 | ||
| 0.076 | 0.04 | 0.076 | Phenylalanine 4-hydroxylase inhibitor | |||
| 0.104 | 0.071 | 0.104 | 5 Hydroxytryptamine 3A agonist | |||
| 0.183 | 0.15 | 0.183 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.049 | 0.016 | 0.049 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.051 | 0.02 | 0.051 | Guanylate cyclase inhibitor | |||
| 0.062 | 0.031 | 0.062 | Ryanodine receptor antagonist | |||
| 0.051 | 0.022 | 0.051 | Geranyltranstransferase inhibitor | 0.041 0.035 CID_66283 | ||
| 0.035 | 0.006 | 0.035 | Vanilloid 2 agonist | 0.025 0.019 CID_66283 | ||
| 0.075 | 0.046 | 0.075 | Histidine decarboxylase inhibitor | |||
| 0.05 | 0.021 | 0.05 | Cyclin D3 inhibitor | |||
| 0.106 | 0.078 | 0.106 | Photosensitizer | |||
| 0.052 | 0.024 | 0.052 | Thymidylate synthase inhibitor | |||
| 0.121 | 0.093 | 0.121 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.07 | 0.043 | 0.07 | Exportin-1 inhibitor | |||
| 0.051 | 0.024 | 0.051 | Mannosidase inhibitor | |||
| 0.046 | 0.02 | 0.046 | Kainate receptor agonist | |||
| 0.189 | 0.165 | 0.189 | Gastrin inhibitor | |||
| 0.133 | 0.11 | 0.133 | CF transmembrane conductance regulator agonist | |||
| 0.047 | 0.024 | 0.047 | Histamine H1 receptor agonist | |||
| 0.071 | 0.05 | 0.071 | Phospholipase D inhibitor | |||
| 0.068 | 0.048 | 0.068 | Carbonic anhydrase VA inhibitor | 0.064 0.053 CID_66283 | ||
| 0.127 | 0.107 | 0.127 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.033 | 0.013 | 0.033 | Purinergic P2Y15 antagonist | |||
| 0.042 | 0.023 | 0.042 | Membrane dipeptidase inhibitor | |||
| 0.076 | 0.058 | 0.076 | MAP kinase kinase 7 inhibitor | |||
| 0.102 | 0.085 | 0.102 | Cholesterol synthesis inhibitor | |||
| 0.042 | 0.025 | 0.042 | Dopamine D5 agonist | |||
| 0.033 | 0.016 | 0.033 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.029 0.019 CID_66283 | ||
| 0.107 | 0.09 | 0.107 | Amylase inhibitor | |||
| 0.04 | 0.026 | 0.04 | Alpha 1d adrenoreceptor agonist | |||
| 0.115 | 0.101 | 0.115 | Vanilloid 1 agonist | 0.113 0.105 CID_66283 | ||
| 0.029 | 0.015 | 0.029 | Hedgehog signaling activator | |||
| 0.054 | 0.04 | 0.054 | Immunoglobulin Fc receptor antagonist | |||
| 0.05 | 0.036 | 0.05 | Lysophosphatidic acid 3 receptor antagonist | |||
| 0.042 | 0.03 | 0.042 | Histamine H2 receptor agonist | |||
| 0.017 | 0.005 | 0.017 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | |||
| 0.029 | 0.017 | 0.029 | Estrogen-related receptor gamma antagonist | |||
| 0.026 | 0.015 | 0.026 | Lysophosphatidic acid receptor 1 agonist | |||
| 0.062 | 0.051 | 0.062 | Carbonic anhydrase V inhibitor | |||
| 0.019 | 0.009 | 0.019 | Carbonic anhydrase X inhibitor | |||
| 0.019 | 0.009 | 0.019 | Carbonic anhydrase VIII inhibitor | |||
| 0.076 | 0.067 | 0.076 | Glutathione S-transferase inhibitor | |||
| 0.038 | 0.029 | 0.038 | GABA uptake inhibitor | |||
| 0.019 | 0.01 | 0.019 | Methylmalonyl-CoA mutase inhibitor | |||
| 0.048 | 0.039 | 0.048 | Squalene epoxidase inhibitor | |||
| 0.068 | 0.06 | 0.068 | Glycine receptor agonist | |||
| 0.068 | 0.061 | 0.068 | CYP2A6 inhibitor | |||
| 0.016 | 0.01 | 0.016 | Purinergic P2Y1 agonist | |||
| 0.015 | 0.008 | 0.015 | Lysophosphatidic acid receptor 3 agonist | |||
| 0.104 | 0.099 | 0.104 | Cathepsin H inhibitor | |||
| 0.101 | 0.096 | 0.101 | Aldehyde dehydrogenase inhibitor | |||
| 0.047 | 0.042 | 0.047 | Prolyl endopeptidase inhibitor | |||
| 0.017 | 0.012 | 0.017 | Telomerase stimulant | |||
| 0.03 | 0.027 | 0.03 | Glutamate (mGluR3) agonist | |||
| 0.088 | 0.086 | 0.088 | Carbonic anhydrase XV inhibitor | |||
| 0.053 | 0.051 | 0.053 | Pregnane X receptor antagonist | |||
| 0.041 | 0.04 | 0.041 | Adenylate cyclase 1 inhibitor | |||
| 0.039 | 0.038 | 0.039 | Nerve growth factor antagonist | |||
| 0.054 | 0.053 | 0.054 | NMDA receptor glycine site agonist | |||
| 0.063 | 0.062 | 0.063 | Catalase inhibitor | |||
| 0.012 | 0.789 | 0.052 | Antiviral (Hepatitis D) | 0.052 0.034 CID_66283 | CID_66283 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |